SCHEMBL24493048

SCHEMBL24493048

c1ccc(-n2c3ccncc3c3cc(-c4cc(-c5cccc(-c6cccc(-c7cncnc7)n6)c5)cc(-c5cccc(-c6cccc(-c7cncnc7)n6)c5)c4)ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.36
▸ PIM1 P11309 1/20 0.33
▸ TNF P01375 1/20 0.33
▸ MAPT P10636 2/20 0.33
▸ MAPK10 P53779 1/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ GRM5 P41594 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ AOC3 Q16853 1/20 0.32
▸ CYP17A1 P05093 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ DRD2 P14416 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24492835 0.92 CYP19A1 (0.46) CYP19A1MAPTMEN1KMT2AHDAC8
SCHEMBL24492836 0.91 MEN1 (0.36) CYP19A1TNFMAPTMAPK10MEN1
SCHEMBL24492823 0.91 ATM (0.39) TNFMAPTMAPK10MEN1KMT2A
SCHEMBL24492782 0.90 ATM (0.42) CYP19A1PIM1MAPTMEN1KMT2A
SCHEMBL15369824 0.87 CYP19A1 (0.54) CYP19A1MAPTMEN1KMT2AHDAC8
SCHEMBL15369843 0.87 CYP19A1 (0.41) CYP19A1TNFMAPTMAPK10MEN1
SCHEMBL24492882 0.87 MAOA (0.38) CYP19A1PIM1TNFMAPTGRM5
SCHEMBL12169093 0.86 KMT2A (0.33) CYP19A1TNFMAPTMAPK10MEN1
SCHEMBL15369929 0.86 CYP19A1 (0.43) CYP19A1TNFMAPTMAPK10MEN1
SCHEMBL15369926 0.86 CYP19A1 (0.43) CYP19A1TNFMAPTMAPK10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 CYP19A1 2451/4885PIM1 2564/4885TNF 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback